Pulmonary arterial hypertension: management in specific medical conditions
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2018, Vol 3, Issue 6
Abstract
Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Due to the narrowing of the blood vessels in the lungs, pul- monary vascular resistance and pulmonary pressures increase. This results in reduced cardiac output, right heart failure and ultimately in death. Pulmonary hypertension, particularly PAH, is an independent risk factor for both peri-operative complications and post-operative mortality. The peri-operative management of patients with PAH is particularly challenging and requires a multidisciplinary approach. Appropriate patient preparation requires an accurate assessment of the severity of pulmonary hypertension, comorbidities and the type of surgery to be performed. Additionally, patients with PAH are more likely to develop an infection, particularly of the respiratory system. Infections are important risk factors for disease exacerbation, often affecting prognosis. For this reason, there is a need for effective prophylactic, diagnostic and rapid therapeutic strategies in PAH patients admitted with suspected infection. While pregnancy is not con- sidered a disease, it is associated with a significant mortality and morbidity risk in patients with PAH and therefore it is contraindicated in this group. Thus, the proper education of patients and effective contraception are necessary in order to minimize health risks. If a woman decides to maintain her pregnancy, careful monitoring, specific treatment optimization and close co-operation with an obstetrician are needed. The proper assessment of the severity of PAH and the optimization of specific treatments are crucial to improve the prognosis of PAH patients in all high-risk conditions. Additionally, the early diagnosis of high-risk conditions allows for early intensive treatment or control, which should be performed at a PAH treatment referral centre. JRCD 2018; 3 (6): 194–198.
Authors and Affiliations
Sylwia Iwańczyk, Tatiana Mularek-Kubzdela
Keywords
Related Articles
- EP ID EP286456
- DOI 10.20418/jrcd.vol3no6.320
- Views 105
- Downloads 0
A 79‑year‑old man with pericardial tumor (RCD code: VI‑1B.4)
A huge pericardial tumor was incidentally detected in 79 year old man during routine transthoracic echocardiography which was not presence in previously performed echocardiography studies (the last was 4 mounths ago). T...
Mediastinal cyst: a case report (RCD code: VI)
We report a case of a 57‑year‑old female patient in whom a mediastinal tumor was found. Differential diagnosis included chiefly allergic alveolitis or an ectopic thymus. The exact nature of the lesion has not been fully...
World Rare Disease Day – 29th of February 2016 III Conference of Rare Cardiovascular Diseases at John Paul II Hospital in Krakow
The third Conference of Rare Cardiovascular Diseases took place at the John Paul II Hospital in Krakow, Poland on the 29th of February 2016. The conference was organized as part of the World Rare Disease Day 2016 annuall...
Journal of Rare Cardiovascular Diseases: “Conquering new territories” – a new educational program on rare diseases for medical acolytes
Dear Readers,Nowadays, we witness dramatic changes in the perception of rare diseases. Thanks to the European Union(EU) regulations but more importantly due to increasing pressure from the spontaneous patients’ organiza...
For one mistake made for not knowing, ten mista kes are made for not looking
And yet again, summer solstice is just behind the cor‑ ner. As the time passes so quickly, do we really have a chance to use it profitability? One way is to study hard and be up‑to‑date. Then we know new and com‑ plex sy...